Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Repurposed Approved and Under Development Therapies for Patients With Early-Onset COVID-19 and Mild Symptoms

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04727424
Recruitment Status : Recruiting
First Posted : January 27, 2021
Last Update Posted : July 7, 2022
Cytel Inc.
McMaster University
Eiger BioPharmaceuticals
RainWater Foundation
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 1, 2023
Estimated Study Completion Date : November 1, 2023
Publications of Results:

Other Publications: